Trials / Unknown
UnknownNCT03924271
Prevalence Study of Iron Deficiency in Patients With Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,200 (estimated)
- Sponsor
- VIFORFRANCE · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite its high prevalence, a recent study conducted by Prof. Cacoub (unpublished) on the french national health insurance database showed that iron deficiency was an underdiagnosed and under-treated co-morbidity. In inflammatory situations, especially during cancer, the measurement of the transferrin saturation factor is only performed in about 10% of cases whereas this measure is recommended in inflammatory situations including cancer (French Health High Authority 2011)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Iron deficiency testing | Blood sample for complete iron status |
Timeline
- Start date
- 2019-05-15
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
- First posted
- 2019-04-23
- Last updated
- 2019-04-23
Source: ClinicalTrials.gov record NCT03924271. Inclusion in this directory is not an endorsement.